• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: INTEGRA LIFE SCIENCES CORP DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL CRANIAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

INTEGRA LIFE SCIENCES CORP DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5; DURASEAL CRANIAL Back to Search Results
Catalog Number 202050
Device Problem Use of Device Problem (1670)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 08/27/2020
Event Type  malfunction  
Manufacturer Narrative
The device was not yet received by the manufacturer for analysis.The plant investigation is in progress and a supplemental medwatch report will be submitted upon completion of the investigation.
 
Event Description
A customer reported that the diluent syringe (blue label) of the 202050 duraseal dural sealant system was inadequate.This was used for a dural tumor procedure on (b)(6) 2020.Product was in contact with the patient; however, there was no patient injury and no surgical delay.
 
Manufacturer Narrative
Duraseal sealant was returned for evaluation.Device history record (dhr) - the dhr review and product analysis of the polymer kit concluded there were no assembly component related failures with the returned product or at the time of release.Failure analysis: integra has performed a thorough review of the reported incident.The sample receive back had the bioset cap pressed down with no red mark showing in the vial (as indicated in the ifu).The grommet was correctly perforated by the bioset spike.There were blue residues of reconstituted peg observed inside the vial (liquid state) borate syringe was found unused with 2.5ml and capped.Spray tips and y connector were received without usage signs.Phosphate syringe was found without the cap engaged to the bioset threads with traces of reconstituted dried blue peg.Sample received back was tested by injecting water inside the vial thru the bioset.There were no issues when injecting the water thru the bioset , or when drawing the liquid out.The peg powder was dissolved, however with the sample received it is not possible to determine the amount of liquid received by the customer, or why they experienced the reported issue.Root cause analysis: the investigation was unable to determine a root cause or confirm the reported incident.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURASEAL DURAL SEALANT SYSTEM 5ML US BOX OF 5
Type of Device
DURASEAL CRANIAL
Manufacturer (Section D)
INTEGRA LIFE SCIENCES CORP
1100 campus drive
1100 campus drive
princeton NJ 08536
MDR Report Key10600968
MDR Text Key209028550
Report Number3003418325-2020-00016
Device Sequence Number1
Product Code NQR
Combination Product (y/n)N
PMA/PMN Number
P040034
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,distri
Type of Report Initial,Followup
Report Date 09/01/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/29/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Catalogue Number202050
Device Lot Number60228900
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer09/10/2020
Date Manufacturer Received11/18/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-